This CSR likely occurs in situ, as evidence in both melanoma and healthy skin shows antibodies with identical V(D)J sequences belonging to different subclasses occurs in parallel with the expression of AID (Saul et al., 2016). The gene discussed is AICDA; the disease is melanoma.